Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

 64.60p
   
  • Change Today:
      0.000p
  • 52 Week High: 64.60
  • 52 Week Low: 31.60
  • Currency: UK Pounds
  • Shares Issued: 540.57m
  • Volume: 0
  • Market Cap: £349.21m
  • RiskGrade: 119
  • Beta: 0.01

Company Listing Data

EPIC APH
Sector Pharma and Biotech
ISIN GB0031030819
Market Sector AIM
Market Segment AMSM
Main Indices FTSE AIM All-Share, FTSE AIM 50, FTSE AIM 100
Country of register Great Britain
Currency British Pound
Market Cap £349.21m
NMS 15,000
Shares in issue 540.57m
Date Listed 23-Dec-2003

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 64.60p
Change Today 0.000p
% Change 0.00 %
52 Week High 64.60
52 Week Low 31.60
Volume 0
Shares Issued 540.57m
Market Cap £349.21m
Beta 0.01
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
24.24% above the market average24.24% above the market average24.24% above the market average24.24% above the market average24.24% above the market average
95.83% above the sector average95.83% above the sector average95.83% above the sector average95.83% above the sector average95.83% above the sector average
Price Trend
74.42% above the market average74.42% above the market average74.42% above the market average74.42% above the market average74.42% above the market average
91.67% above the sector average91.67% above the sector average91.67% above the sector average91.67% above the sector average91.67% above the sector average
Income Not Available
Growth
49.61% below the market average49.61% below the market average49.61% below the market average49.61% below the market average49.61% below the market average
68.75% below the sector average68.75% below the sector average68.75% below the sector average68.75% below the sector average68.75% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 5
Sell 1
Strong Sell 0
Total 8
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

Alliance Pharma Key Personnel

CFO Andrew Franklin
Chair Camillo Pane
CEO Nick Sedgwick

Top of Page